Jupiter Neurosciences, Inc.
JUNS
$5.24
-$0.76-12.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -175.25% | -254.36% | -466.30% | -133.70% | 9.16% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 171.90% | 682.94% | 3,181.00% | 2,240.00% | 1,309.50% |
| Total Other Non-Cash Items | 141.22% | 136.76% | 5,016.53% | 772.72% | -15.32% |
| Change in Net Operating Assets | 102.04% | 104.10% | -384.20% | -239.37% | -250.15% |
| Cash from Operations | -17.80% | -38.42% | -1,691.05% | -1,032.72% | -996.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5,867.91% | 3,928.88% | -99.44% | -93.20% | -77.20% |
| Total Debt Repaid | 93.80% | 93.80% | -- | -- | -- |
| Issuance of Common Stock | -96.33% | -- | 100.00% | 100.00% | 400.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -28.50% | -28.99% | 2,254.89% | 1,448.14% | 1,628.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.74% | -99.47% | 1,318.18% | 14,434.62% | 36,076.00% |